Evidence map›Paper›PMID 42107968›Full record

ArticleBritish journal of clinical pharmacology2026

Practical dose ranges supporting target vancomycin exposure with AUC-guided dosing in overweight and obese patients: A multicentre retrospective study.

Aiju Endo, Yuki Hanai, Takaya Namiki, Kazumi Hanawa, Hideki Hashi, Daiki Asakawa, Yoshiaki Yokoyama, Riku Maruyama, Shun Tsujimura, Yuki Igarashi and 3 more

Abstract readMulticenter Study
In one paragraph

Article in British journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aiju EndoDepartment of Pharmacy, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.ORCID https://orcid.org/0000-0003-4534-8433
Yuki HanaiDepartment of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan.ORCID https://orcid.org/0000-0002-4606-7150
Takaya NamikiDepartment of Pharmacy, Tokyo Bay Urayasu Ichikawa Medical Centre, Chiba, Japan.ORCID https://orcid.org/0009-0000-4710-9693
Kazumi HanawaDepartment of Pharmacy, Kameda Medical Centre, Chiba, Japan.
Hideki HashiPharmacy, Minato pharmacy, Chiba, Japan.
Daiki AsakawaDepartment of Pharmacy, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
Yoshiaki YokoyamaDepartment of Pharmacy, Kameda Medical Centre, Chiba, Japan.
Riku MaruyamaDepartment of Pharmacy, Kameda Medical Centre, Chiba, Japan.
Shun TsujimuraDepartment of Pharmacy, Kameda Medical Centre, Chiba, Japan.
Yuki IgarashiDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Yuki EnokiDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Kaori MatsumotoDepartment of Pharmacy, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
Kazuaki MatsumotoDivision of Pharmacodynamics, Keio University Faculty of Pharmacy, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimEvidence supporting area under the concentration-time curve (AUC)-guided vancomycin dosing in overweight and obese patients remains limited. This multicentre retrospective study aimed to identify pragmatic loading dose (LD) and maintenance dose (MD) ranges associated with target AUC attainment in this population.

methodsPatients aged ≥15 years with a body mass index (BMI) ≥ 25 kg/m

resultsAmong 209 patients (median BMI 27.2 kg/m

conclusionIn this multicentre real-world cohort of overweight/obese adults, an LD around 20 mg/kg (ceiling 2 g) was associated with early AUC

Indexed as

Anti-Bacterial AgentsObesityOverweightVancomycinAdultAgedArea Under CurveBody Mass IndexDose-Response Relationship, DrugFemaleGlomerular Filtration RateHumansJapanMaleMiddle AgedRetrospective StudiesAnti-Bacterial AgentsVancomycinAUCloading dosemaintenance doseoverweight and obese patientsvancomycin

Identifiers

PMID42107968
PMCPMC13519779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.